Influence of the SCN1A IVS5N + 5 G>A Polymorphism on Therapy with Carbamazepine for Epilepsy

• Sterjev Z,
• Kiteva G,
• Cvetkovska E,
• Petrov I,
• Kuzmanovski I,
• Ribarska T,
• Nestorovska K,
• Matevska N,
• Trajkovik-Jolevska S,
• Dimovski A,
• Suturkova Lj

Affiliations

Sterjev Z

Institute for Pharmaceutical Chemistry, Faculty of Pharmacy, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Kiteva G

Clinic of Neurology, Faculty of Medicine, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Cvetkovska E

Clinic of Neurology, Faculty of Medicine, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Petrov I

Clinic of Neurology, Faculty of Medicine, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Kuzmanovski I

Clinic of Neurology, Faculty of Medicine, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Ribarska T

Institute for Pharmaceutical Analysis, Faculty of Pharmacy, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Nestorovska K

Institute for Pharmaceutical Chemistry, Faculty of Pharmacy, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Matevska N

Institute for Pharmaceutical Chemistry, Faculty of Pharmacy, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Trajkovik-Jolevska S

Institute for Pharmaceutical Analysis, Faculty of Pharmacy, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Dimovski A

Institute for Pharmaceutical Chemistry, Faculty of Pharmacy, University "St. Cyril and Methodius, Skopje, Republic of Macedonia

Suturkova Lj

Institute for Pharmaceutical Chemistry, Faculty of Pharmacy, University "St. Cyril and Methodius, Skopje, Republic of Macedonia